HERPES SIMPLEX VIRUS TYPE 1 & 2 QUALITATIVE PCR - FLUID

Herpes Simplex Virus (HSV) Type 1 & 2 Qualitative PCR - Fluid is an advanced molecular diagnostic test used to detect the presence of Herpes Simplex Virus Type 1 (HSV-1) and Type 2 (HSV-2) DNA in body fluid specimens. The test utilizes highly sensitive Polymerase Chain Reaction (PCR) technology to identify active herpes virus infection with excellent accuracy and reliability.

HSV-1 commonly causes oral herpes and can also cause genital infections, while HSV-2 is primarily associated with genital herpes. In certain situations, herpes viruses can cause serious infections involving the skin, eyes, central nervous system, and other organs. Early and accurate diagnosis is important for timely treatment and prevention of complications.

Benefits of the Test

• Highly sensitive detection of HSV-1 and HSV-2 DNA.
• Provides rapid confirmation of active herpes infection.
• Differentiates between HSV Type 1 and Type 2.
• Supports early diagnosis and treatment decisions.
• Useful for neurological, ocular, and systemic HSV infections.
• Detects infection even when viral levels are low.
• Provides reliable molecular diagnostic results.
• Supports effective patient management.

Why Doctors Recommend This Test

Doctors recommend HSV Type 1 & 2 Qualitative PCR testing for patients with suspected herpes infections, vesicular lesions, genital ulcers, encephalitis, meningitis, ocular infections, neonatal herpes, unexplained neurological symptoms, or when confirmation of active HSV infection is required.

The test helps identify active viral infection and supports appropriate antiviral treatment planning.

Preparation Before Test

• No fasting is generally required.
• A suitable body fluid specimen is collected as advised by the physician.
• Specimens may include cerebrospinal fluid, vesicle fluid, ocular fluid, or other clinically relevant samples.
• Inform your doctor about ongoing antiviral therapy.
• Follow all specimen collection instructions carefully.
• Ensure timely transport of the sample to the laboratory.

Normal Reporting Time

Most Herpes Simplex Virus Type 1 & 2 Qualitative PCR - Fluid reports at Focus Diagnostics are available within 2–3 hours for specimen processing and molecular workflow initiation. Final PCR analysis, validation, and reporting are generally completed within a few working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with suspected herpes simplex infection.
• Patients with genital ulcers or oral lesions.
• People with suspected HSV encephalitis or meningitis.
• Individuals with ocular herpes infections.
• Newborns suspected of neonatal herpes infection.
• Immunocompromised patients.
• Patients with unexplained neurological symptoms.
• Individuals requiring molecular confirmation of HSV infection.

Detailed Information

Herpes Simplex Viruses are common viral pathogens that infect millions of individuals worldwide. HSV-1 is traditionally associated with oral herpes, while HSV-2 is more commonly linked to genital herpes. However, both virus types can infect multiple body sites and cause a wide spectrum of clinical disease.

After initial infection, herpes viruses establish lifelong latency within nerve cells and may reactivate periodically. Reactivation can lead to recurrent lesions, pain, and viral shedding. In some individuals, especially newborns and immunocompromised patients, HSV infections can become severe and potentially life-threatening.

Qualitative PCR testing directly detects viral DNA and is considered one of the most sensitive methods for diagnosing active HSV infection. Unlike antibody testing, which measures immune response, PCR confirms the presence of viral genetic material in the specimen being tested.

The test is particularly valuable for diagnosing central nervous system infections such as HSV encephalitis, where rapid diagnosis is critical for patient survival and neurological outcomes. It is also useful for evaluating genital lesions, ocular infections, neonatal herpes, and atypical presentations.

Body fluid specimens collected from the affected site provide direct evidence of infection. The test can identify HSV DNA even when viral concentrations are low, improving diagnostic accuracy and supporting timely antiviral therapy.

Results should always be interpreted alongside clinical findings, physical examination, imaging studies, and additional laboratory investigations when necessary. Further testing may be recommended depending on the patient's symptoms and medical history.

At Focus Diagnostics, Herpes Simplex Virus Type 1 & 2 Qualitative PCR testing is performed using advanced molecular diagnostic platforms, validated PCR methodologies, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful infectious disease diagnostic results.